THAP1 and Dystonia: Comparing initial and long-term clinical outcomes in DYT-KMT2B with other types of monogenic dystonia, initial improvement is significant and comparable to outcomes observed in DYT-THAP1 (Panov et al., 2013; Danielsson et al., 2019).